FIA
GHDX

FNY Investment Advisers’s Genomic Health, Inc. GHDX Stock Holding History

FNY Investment Advisers’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-158
Closed -$10K – 1069
2018
Q4 		$10K Buy
+158
New +$11.1K ﹤0.01% 465

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FNY Investment Advisers's GHDX Position: Q1 2019 in Review

FNY Investment Advisers sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 158 shares — an estimated $10K sold.

FNY Investment Advisers first reported a position in GHDX in Q4 2018 and held it in 1 quarter. The position peaked at $10K in Q4 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • FNY Investment Advisers reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 158 Genomic Health, Inc. shares in Q1 2019, an estimated $10K.
  • FNY Investment Advisers first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 1 quarter.
  • FNY Investment Advisers's Genomic Health, Inc. position peaked at $10K in Q4 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.